CTI Biopharma

formerly CTI BioPharma Cell TherapeuticsAcquired

Developing novel therapies for rare blood-related cancers

Seattle, United States · Founded 1991 · $50.7M raised

Employees
51–200
Founded
1991
Business Model
B2B
Total Funding
$50.7M
Last Round
$50.7M Corporate RoundJan 2025
Rounds
1
Acquisition Date
May 2023

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 2 investors for this company. The full record is or through the API.

About

CTI BioPharma Corp was a biopharmaceutical company focused on acquiring, developing, and commercializing novel targeted therapies for blood-related cancers with unmet medical needs. The company's primary commercial product was Vonjo (pacritinib), approved by the FDA in 2022 for the treatment of adults with intermediate or high-risk myelofibrosis. Founded in 1991 and headquartered in Seattle, Washington, CTI BioPharma was listed on NASDAQ (CTIC) until its acquisition by Swedish Orphan Biovitrum AB (Sobi) in June 2023 for approximately $1.7 billion.

Summary

CTI Biopharma is a Biotech company based in Seattle, United States, founded in 1991. It has raised $50.7M in total across 1 round, most recently a $50.7M Corporate Round in Jan 2025. Investors include DRI Healthcare Trust and New Enterprise Associates.

Funding & Exit History

Corporate RoundCorporate Round2025 (est.)
$50.7M

Sign up to see all 5 events

Funding: Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CTI Biopharma on Indexed.vc
<a href="https://indexed.vc/companies/cti-biopharma"><img src="https://indexed.vc/api/badge/company/cti-biopharma" alt="CTI Biopharma on Indexed.vc" width="260" height="76" /></a>